BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Budget/Appropriations BUD

Energy Basic Research Funding ---Advanced Research Projects Agency-Energy ---DOE Office of Science ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for FDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Renewable Chemicals/Bio-based Products ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---EPA Safer Choice Program Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Contacted: Environmental Protection Agency (EPA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Treasury, Dept of; Commerce, Dept of (DOC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); State, Dept of (DOS); Office of Management & Budget (OMB)

Bills named: S. 3042 (115th), S. 2976 (115th), H.R. 5895 (115th), S. 3158 (115th), H.R. 5961 (115th), H.R. 2 (115th), S. 2975 (115th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing --------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); Defense, Dept of (DOD); Commerce, Dept of (DOC); SENATE; Treasury, Dept of; Natl Security Council (NSC); Securities & Exchange Commission (SEC)

Health Issues HCR

340B Drug Discount Program ---Program Implementation & Oversight ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 4710: 340B Pause Act ---H.R. 5598: 340B Optimization Act ---S. 2453: Ensuring the Value of the 340B Program Act Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---Transfer of Authority for National Strategic Stockpile ------S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA) ---National Biodefense Strategy Biosimilars ---Access to Samples for Testing ---Coding ---Naming ---Interchangeability and Pharmacy Substitution ---S. 974/H.R. 2212: CREATES Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Patient-Focused Drug Development ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---FDA Management & Financial Accountability ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---Counterfeiting Drug Pricing ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Drug Product Communications ---H.R. 1703: The Medical Products Communications Act of 2017 ---S. 2157: Drug-Price Transparency in Communications Act ---Direct to Consumer Advertising Disclosures ------H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------H.R. 6157: Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 Foreign Drug Data Protection Laws Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for FDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---S. 974/H.R. 2212: CREATES Act of 2017 ---H.R. 749: Lower Drug Costs Through Competition Act Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---IP Provisions Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Orphan Drug Issues ---Tax Credit Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education

Contacted: Securities & Exchange Commission (SEC); SENATE; Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); State, Dept of (DOS); Food & Drug Administration (FDA); Treasury, Dept of; Defense, Dept of (DOD); Commerce, Dept of (DOC)

Bills named: S. 2769 (115th), S. 2669 (115th), H.R. 5598 (115th), S. 2665 (115th), S. 771 (115th), H.R. 6505 (115th), S. 637 (115th), H.R. 749 (115th), S. 2976 (115th), S. 2453 (115th), H.R. 6157 (115th), S. 1369 (115th), H.R. 5002 (115th), H.R. 6 (115th), H.R. 2212 (115th), H.R. 1840 (115th), H.R. 5590 (115th), S. 2157 (115th), H.R. 1703 (115th), H.R. 4710 (115th), H.R. 6378 (115th), S. 1688 (115th), H.R. 2974 (115th), S. 974 (115th), H.R. 5473 (115th), S. 2852 (115th), S. 2680 (115th), H.R. 5961 (115th), S. 469 (115th), S. 1348 (115th), S. 3158 (115th), H.R. 5806 (115th), H.R. 3219 (115th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act ---Toomey Amendment to H.R.6147 - Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act for FY 2019 Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Biorefineries (non-funding) ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Energy Basic Research Funding ---DOE Office of Science ---Advanced Research Projects Agency-Energy ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act ---H.R. 5212/S.2519: Greener Fuels Act ---EPA's Issuance of Small Refinery Waivers ---Administratively Extend Reid Vapor Pressure (RVP) relief to E15

Contacted: Treasury, Dept of; Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Defense, Dept of (DOD); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Natl Security Council (NSC); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); White House Office; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2 (115th), H.R. 5895 (115th), S. 2975 (115th), S. 2005 (115th), H.R. 5961 (115th), S. 517 (115th), S. 2519 (115th), H.R. 6147 (115th), H.R. 5212 (115th), S. 2976 (115th), H.R. 1311 (115th), H.R. 4118 (115th), S. 3042 (115th)

Trade (domestic/foreign) TRD

Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Foreign Drug Data Protection Laws Intellectual Property International Enforcement ---Compulsory Licensing ---Chile ---Malaysia North American Free Trade Agreement (NAFTA) Renegotiation ---IP Provisions ---Pricing and Reimbursement Provisions ---Ag-Biotech Provisions Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals

Contacted: Treasury, Dept of; White House Office; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); SENATE; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 469 (115th)

Agriculture AGR

Agricultural Education Policy Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act EPA Regulations on Biotechnology ---H.R. 1029 Pesticide Registration Act ---Efficient Science-Based Reviews of Biotech Products Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 One Health ---S. 2615: Advancing Emergency Preparedness Through One Health Act Potential Regulation of New Genetic Editing/Modification Technologies Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Potential Revisions to Part 340 Regulations ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Treasury, Dept of; Office of Management & Budget (OMB); Patent & Trademark Office (PTO); SENATE; Environmental Protection Agency (EPA); State, Dept of (DOS); Commerce, Dept of (DOC); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); White House Office; Agriculture, Dept of (USDA); Natl Institutes of Health (NIH)

Bills named: H.R. 2 (115th), S. 2615 (115th), S. 2476 (115th), H.R. 1029 (115th), S. 3042 (115th), H.R. 5961 (115th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Capital Formation Investment Incentives ---Reform of Net Operating Loss Rules ---H.R. 6756: American Innovation Act of 2018 Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---HR 3149/S. 1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act Qualified Small Business Stock (QSBS) Research & Development Tax Credit Reforms ---Refundable R&D Credit

Contacted: State, Dept of (DOS); White House Office; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Security Council (NSC); Natl Institutes of Health (NIH); Defense, Dept of (DOD); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Treasury, Dept of; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); SENATE

Bills named: S. 1980 (115th), H.R. 4118 (115th), H.R. 6756 (115th), S. 2005 (115th), H.R. 3149 (115th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---March-In Rights Foreign Drug Data Protection Laws Intellectual Property International Enforcement ---Compulsory Licensing ---Chile ---Malaysia Inter Partes Review ---Implementation of the America Invents Act of 2011 ---H.R. 5340/S. 1390: STRONGER Patents Act ---H.R. 6264: Restoring America's Leadership Act ---Biomedical Innovation Protection Act of 2018 (Discussion Draft House/Senate) North American Free Trade Agreement (NAFTA) Renegotiation ---IP Provisions Patent Reform ---H.R. 5340/S. 1390: STRONGER Patents Act Compulsory Licensing ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Patent Fees ---S. 3416: USPTO Fees Act Diversity of Patent Authorship ---H.R. 6390/S.3483: SUCCESS Act Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017

Contacted: Patent & Trademark Office (PTO); White House Office; State, Dept of (DOS); Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Treasury, Dept of; Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Natl Security Council (NSC); Natl Institutes of Health (NIH)

Bills named: S. 1390 (115th), H.R. 2655 (115th), H.R. 6390 (115th), H.R. 5340 (115th), S. 3416 (115th), H.R. 6505 (115th), S. 3483 (115th), H.R. 6264 (115th), S. 791 (115th)

Small Business SMB

Capital Market Enhancements ---SEC Small Business Forum ---Amended Definition of Smaller Reporting Company ---S. 488: JOBS and Investor Confidence Act Proxy Advisory Services ---Impact of Policies on Small Public Companies ---H.R. 4015: Corporate Governance Reform and Transparency Act of 2017 ---H.R. 10: Financial Choice Act Sarbanes Oxley Section 404 (b) ---H.R. 1645/S. 2126: Fostering Innovation Act ---Small Issuer Exemption ---H.R. 10: Financial Choice Act ---H.R. 3978: TRID Improvement Act Short Selling Transparency Small Business IP Training ---H.R. 2655/S.791: Small Business Innovation Protection Act of 2017 XBRL Exemption for Small Public Companies ---H.R. 5054: Small Company Disclosure Simplification Act ---H.R. 10: Financial Choice Act

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); State, Dept of (DOS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Natl Security Council (NSC); Securities & Exchange Commission (SEC); Defense, Dept of (DOD); Treasury, Dept of; White House Office; Agriculture, Dept of (USDA)

Bills named: S. 2126 (115th), H.R. 4015 (115th), H.R. 10 (115th), H.R. 2655 (115th), S. 791 (115th), H.R. 1645 (115th), S. 488 (115th), H.R. 5054 (115th), H.R. 3978 (115th)

Medicare/Medicaid MMM

Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculation Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018

Contacted: Defense, Dept of (DOD); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Natl Security Council (NSC); Securities & Exchange Commission (SEC); White House Office; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); SENATE; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Treasury, Dept of; U.S. Trade Representative (USTR); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6505 (115th), S. 771 (115th), S. 1688 (115th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---EPA Safer Choice Program Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2: Agriculture and Nutrition Act ---S.3042: Agriculture Improvement Act ---H.R. 3149/S.1980: Renewable Chemicals Act of 2017 ---H.R. 4118/S.2005: Master Limited Partnership Parity Act ---S.3296: Sustainable Chemistry Research and Development Act of 208 Chemical Weapons Convention ---Coverage of Unscheduled Biomediated Chemicals

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Defense, Dept of (DOD); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); White House Office; Food & Drug Administration (FDA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Treasury, Dept of; SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Natl Security Council (NSC)

Bills named: H.R. 4118 (115th), S. 3042 (115th), S. 2976 (115th), H.R. 5961 (115th), S. 2005 (115th), S. 3296 (115th), H.R. 2 (115th), H.R. 3149 (115th), S. 1980 (115th)

Consumer Issues/Safety/Products CSP

Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Review and Labeling of Food Derived from Biotechnology ---Implementation of Disclosure Law

Contacted: SENATE; Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); White House Office; Treasury, Dept of; Defense, Dept of (DOD); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Security Council (NSC); Agriculture, Dept of (USDA); State, Dept of (DOS); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Bills named: S. 469 (115th), H.R. 5002 (115th), S. 2476 (115th), H.R. 5961 (115th), H.R. 5806 (115th), H.R. 6 (115th), H.R. 5590 (115th), S. 2680 (115th), S. 2665 (115th), H.R. 5473 (115th), S. 2669 (115th), S. 2769 (115th)

Animals ANI

Genetically Engineered (GE) Animals ---Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---H.R. 5961/S.2476: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------Amendment on GE Salmon Labeling ---The Animal Drug User Fee Reauthorization Act of 2018 One Health ---S. 2615: Advancing Emergency Preparedness Through One Health Act

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Treasury, Dept of; Securities & Exchange Commission (SEC); SENATE; Office of Management & Budget (OMB); State, Dept of (DOS); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); White House Office; Defense, Dept of (DOD)

Bills named: H.R. 5961 (115th), S. 2476 (115th), S. 2615 (115th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 4118/S. 2005: Master Limited Partnership Parity Act ---Toomey Amendment to H.R.6147 - Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act for FY 2019 Biomass Programs (Non-Funding) ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Biorefineries (non-funding) ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act Energy Basic Research Funding ---DOE Office of Science ---Advanced Research Projects Agency-Energy ---H.R.5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 Funding for Biofuels ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5895/S.2975: Energy and Water Development and Related Agencies Appropriations Act for FY 2019 ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biomass Crop Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for Biorefineries ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---H.R. 2: Agriculture and Nutrition Act ---S. 3042: Agriculture Improvement Act ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Renewable Fuel Standard (RFS) ---Changes to the Point of Obligation under the RFS ---RFS Reform ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act ---H.R. 5212/S.2519: Greener Fuels Act ---EPA's Issuance of Small Refinery Waivers ---Administratively Extend Reid Vapor Pressure (RVP) relief to E15

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); State, Dept of (DOS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Defense, Dept of (DOD); Patent & Trademark Office (PTO); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Treasury, Dept of; Office of Management & Budget (OMB); White House Office; Natl Institutes of Health (NIH)

Bills named: H.R. 5212 (115th), H.R. 6147 (115th), S. 2519 (115th), S. 2975 (115th), H.R. 5961 (115th), S. 2005 (115th), S. 2976 (115th), S. 517 (115th), S. 3042 (115th), H.R. 2 (115th), H.R. 5895 (115th), H.R. 4118 (115th), H.R. 1311 (115th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---Transfer of Authority for National Strategic Stockpile ------S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA) ---National Biodefense Strategy Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Natl Security Council (NSC); SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Treasury, Dept of; Natl Institutes of Health (NIH); White House Office; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC)

Bills named: S. 2852 (115th), S. 3158 (115th), H.R. 6378 (115th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ------Transfer of Authority for National Strategic Stockpile ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAIA) ---National Biodefense Strategy Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019

Contacted: Environmental Protection Agency (EPA); Treasury, Dept of; Defense, Dept of (DOD); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); White House Office; Commerce, Dept of (DOC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Natl Security Council (NSC)

Bills named: H.R. 5961 (115th), S. 3158 (115th), S. 2852 (115th), S. 2976 (115th), H.R. 6378 (115th)